Cempra
is a pharmaceutical company that researches and develops novel antibacterial therapeutics for the treatment of infectious diseases... Read moreCempra
is a pharmaceutical company that researches and develops novel antibacterial therapeutics for the treatment of infectious diseases... Read more
Interim-CEO
David Zaccardelli
News
Nov 19, 2018
BioPortfolio
Cempra: Cempra Inc CEMP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250
Aug 01, 2018
BioPortfolio
Cempra: Cempra Inc CEMP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 23, 2018
BioPortfolio
Cempra: Cempra Inc CEMP Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300
Dec 02, 2017
BioPortfolio
Cempra: Cempra Inc CEMP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14112017 Prices from USD $250
Nov 07, 2017
The Business Journals
Cempra: As merger closes, Cempra now trading as Melinta
Nov 06, 2017
Benzinga
Cempra: Melinta Therapeutics Announces Successful Completion of Merger
Nov 04, 2017
DirectorsTalk Interviews
Cempra: Cempra Announces Preliminary Results of 2017 Stockholder Vote
Nov 03, 2017
The Business Journals
Cempra: How Cempra's shareholder vote on Melinta merger shook out
Nov 02, 2017
BioCentury
Cempra: Management Tracks: Melinta, Lundbeck
Nov 01, 2017
WRAL TechWire
Cempra: Melinta, Cempra name new CEO of combined company
Cempra Competitors
1
2
3
4
5
6
7
8
9
10